Hamburgisches Forschungsinstitut fuer CED, HaFCED e.K.

Hamburg 20251

0 studies enrolling now · 1 studies all time

What they study most

Crohn Disease

Studies at this site

• A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease — Completed